Eli Lilly (LLY) is set to announce Q4 earnings results, with analysts expecting positive growth driven by key drugs and new ...

Eli Lilly will announce Q4 2024 results, with analysts estimating $13.7 billion in sales and $4.94 EPS, alongside a revenue growth outlook for 2024.

Cramer said he needs more details from Eli Lilly that suggest next year will be successful, and he's optimistic about Bristol Myers's new schizophrenia drug. Cramer added that he's expecting ...

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said ... against Valhalla was filed in the Eastern District of New York. Lilly said Thrive has designed its website and advertising materials ...

NEW YORK — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The Standard & Poor’s 500 ...

Jan 14 (Reuters) - Eli Lilly's (LLY.N), opens new tab stock tumbled 8% on Tuesday ... She has a postgraduate degree in International Journalism from City, University of London.